E Cannabis Central: These Companies Intend To Become Major Players In Europe

  • acquired Spain-based licensed cannabis producer Cáñamo y Fibras Naturales, S.L. complementing the Company's existing production site in Denmark, (Spectrum Cannabis Denmark), as well as its ISO 13485 certified Storz and Bickel facility in Germany (Spektrum Cannabis Germany).
  • partnered with Alcaliber SA to cultivate marijuana and extract its oil at its Spanish facilities for worldwide sale,
  • bought C3 Cannabinoid Compound, a German company that specializes in cannabinoid-based medical therapies used by European physicians,
  • bought British skincare and wellness outfit This Works this past May and
  • acquired Annabis Medical which will operate as Spectrum Cannabis Czech.

For a detailed financial analysis please go here.

As of the close of business on Aug. 26th Canopy's stock is down 52% from its recent peak on April 29th, 2019.

10. Cronos Group Inc. (NASDAQ: CRON; TSX: CRON) engages in the production and sale of cannabis in Canada, Poland and Germany.

Cronos has:

  • a 5-year exclusive distribution agreement with G.Pohl-Boskamp in Germany allowing it to distribute its product to over 12,000 pharmacies in the country and
  • a 5-year exclusive distribution agreement with Delfarma Sp. Zo.o allowing it to distribute its products to over 5,000 pharmacies and more than 200 hospitals representing approximately 40% of the Polish domestic market.

For a detailed financial analysis please go here.

As of the close of business on Aug. 26th Cronos' stock is down 52% from its recent peak on March 5th, 2019.

11. Aphria Inc. (TSX:APHA; NYSE:APHA) is one of Canada’s lowest-cost medical cannabis producers of medical cannabis.


  • has been awarded a fifth lot (the maximum allowed) for the cultivation of medical cannabis in Germany - it is the only licensed producer in Germany with permission to grow all three strains of medical cannabis approved by German Federal Institute for Drugs and Medical Devices - affirming it's leading position in the German medical cannabis market.
  • is building an 8,000 square meter indoor growing facility in Neumünster and expects to be in a position to supply Germany's first domestically-grown medical cannabis in early calendar 2020,
  • is completing work on a state-of-the-art GMP-certified cannabis vault in Bad Bramstedt, Germany, for the import of cannabis flowers and oil,
  • has entered into a 15% strategic partnership (with the possibility of increasing ownership to 50% under certain conditions) with Denmark-based Schroll Medical (a subsidiary of a prominent European flower producer), to pursue the cultivation and worldwide distribution of organic, EU GMP-certified medical cannabis. To that end Aphria has just completed its first transfer of plant cuttings to Schroll,
  • has a 25.1% interest in Berlin-based Schöneberg Hospital, which provides it access to both doctors and patients for education on the benefits of medical cannabinoids,
  • has introduced a CBD-based nutraceutical and cosmetics product line for the German market, produced in the EU and distributed by CC Pharma, a subsidiary of Aphria with access to more than 13,000 pharmacies throughout Germany, that it acquired back in January of this year and
  • has received the first import license for medical cannabis from the Malta Medicines Authority that will enable its Malta-based subsidiary ASG Pharma, a high-capacity EU GMP-certified lab, to become a cornerstone in testing, research and development of medical cannabis in Europe.

For a detailed financial analysis please go here.

As of the close of business on Aug. 26th Aphria's stock is down 44% from its recent peak on February 5th, 2019.


The pot stocks that have entered the European market are currently performing worse than the market as a whole, on average, but that should change given their early positioning in the burgeoning European market.Please refer to my most recent exclusive articles on TalkMarkets for the average performance of 7 other baskets of pot stocks.

1 2 3 4
View single page >> |
How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.


Leave a comment to automatically be entered into our contest to win a free Echo Show.